Firefly Neuroscience Inc

This management proposal asks stockholders to cast a non-binding advisory vote to approve the Company’s disclosed executive compensation program. Management is seeking this advisory approval to obtain stockholder feedback on pay practices that include base salaries, discretionary cash bonuses, equity awards (stock and option grants), and other elements described in the proxy statement; while non-binding, the Compensation Committee and Board state they will review the results when making future compensation decisions. The request is standard for public companies and is intended to reinforce alignment between executives’ incentives and long-term stockholder value through equity-based awards. The context includes recent hiring and grants to named executive officers and the Company’s reliance on equity incentives to attract and retain personnel in a capital-constrained environment. The vote is advisory only and will not change compensation mechanically, but a negative outcome could prompt the Compensation Committee to modify pay practices, grant structures, or disclosure. The Board recommends a “FOR” vote and justifies it by noting the program’s components and the role of equity in aligning interests; they also emphasize that the vote’s outcome will inform future decisions. From a governance perspective, the proposal raises typical considerations about pay-for-performance linkage, the prevalence of discretionary bonus elements, and the scale of equity grants relative to dilution. Analysts evaluating the proposal should consider the Company’s recent net losses, share-based compensation levels disclosed in the pay tables, and the potential dilution from outstanding and proposed awards when assessing whether current compensation practices are likely to drive long-term shareholder value. Overall, the proposal is low legal risk because it is advisory, but a poor vote outcome could signal investor dissatisfaction and lead to reputational or governance responses from the Board and Compensation Committee.

This proposal requests shareholder approval to increase the equity reserve under the Company’s 2024 Long-Term Incentive Plan by 2,000,000 shares (to a total Plan Share Limit of 3,707,496) and to adopt an updated evergreen mechanism that automatically increases the reserve annually by the lesser of 4% of outstanding shares or a Board-determined amount through 2035. Management frames the change as necessary to preserve the Company’s ability to grant equity-based awards used to attract, retain and motivate employees, directors and consultants; the Board also cites compliance with stock exchange requirements and the need to allow certain options to qualify as incentive stock options under Section 422 of the Code. From a governance and capital-structure perspective, increasing the reserve and adopting an evergreen feature raises dilution considerations — analysts should model incremental potential dilution from the added 2,000,000 shares plus annual evergreen increases and compare that to current outstanding shares and expected hiring/granting activity. The Board’s recommendation rests on the operational imperative of using equity for compensation given limited cash resources and the Company’s stage and hiring needs. However, shareholders should weigh this operational rationale against the risk of shareholder value dilution and monitor grant practices (holding periods, performance vesting, repricing prohibitions) and disclosure around future grants. The proposal also interacts with Proposal 5 (authorized share reduction): while the Company simultaneously seeks to reduce total authorized shares to lower franchise taxes, it is requesting a meaningful increase in the Plan reserve; investors should confirm that the authorized share structure post-approval will accommodate both the Plan increase and existing outstanding shares. If approved, the change will permit management to continue to use equity incentives; if rejected, the Company may need to seek alternative retention tools or request a future increase with a different structure. The amendment’s inclusion of a formulaic evergreen provision shifts future share-authorization increases partly from shareholder votes to an automatic formula, which may be convenient operationally but reduces direct shareholder control over future dilution; appropriate guardrails and disclosure will be important going forward.

This management proposal asks stockholders to approve a certificate of amendment that would reduce the Company’s total authorized share count from 5,001,000,000 to 101,000,000, primarily to lower annual Delaware franchise tax expense, which is in part determined by authorized shares. Management’s rationale is straightforward: materially reduce recurring state franchise tax obligations and conserve capital for operations. The Board says the reduced authorization will still be sufficient for foreseeable needs (capital raises, equity compensation, strategic transactions) but acknowledges that the reduced ceiling reduces flexibility and could require a future shareholder vote to increase authorized shares if unanticipated opportunities arise. From a governance and transaction-risk standpoint, reducing authorized shares carries the trade-off of lower taxes versus potential delays or frictions in executing dilutive corporate actions (e.g., financings, M&A) if additional authorized shares become necessary. Analysts should verify that outstanding shares, the increased Plan reserve in Proposal 4, and other commitments can be accommodated within the lower authorized cap if both proposals are approved, and consider timing (the Board may file the amendment after the meeting but can abandon filing if conditions change). The vote requirement is a majority of the voting power of all outstanding shares, and abstentions or broker non-votes count effectively as votes against, raising the practical bar for passage. If approved and filed, the amendment will not change outstanding shares or rights, but will change the ceiling for future issuance, which is a corporate governance consideration for investors.

This management proposal asks shareholders to grant the proxy holders authority to adjourn or postpone the Annual Meeting to allow additional solicitation of votes if any proposal lacks sufficient support at the time of the meeting. Management seeks this procedural authority to avoid losing the opportunity to secure approval for material proposals (such as the Plan amendment or Certificate of Amendment) due to timing or broker non-votes, by permitting an adjournment rather than immediate defeat. Such adjournments are common corporate practice and can be used both to solicit additional institutional or retail votes and to resolve outstanding broker non-votes by seeking instructions from beneficial owners. The governance implication is that an approved adjournment can concentrate power in management to continue solicitation efforts after the meeting date; however, shareholders retain ultimate approval because adjournment itself requires a vote. Analysts should consider whether the Company is likely to need additional solicitation (for example, if proposals require a high affirmative threshold or broker non-votes are expected), and whether adjournment could materially change outcomes. The Board recommends a "FOR" vote, arguing it preserves flexibility to secure requisite approvals and avoid the costs and delays of reconvening a separate special meeting. On the other hand, frequent or strategic use of adjournments may concern some investors if used to overcome clear shareholder opposition; the Company’s representation that adjournment would be used only to solicit additional proxies mitigates that concern. Overall, the proposal is procedural but can be material in close-vote scenarios where additional time materially affects the likelihood of approval.